Indicators of cellular renewal of gastric epitheliocytes in indigenous and alien inhabitants of the Republic of Tyva with atrophic gastritis
https://doi.org/10.31550/1727-2378-2022-21-2-30-33
Abstract
Study Objective: to study the indicators of apoptosis and proliferation in gastric epitheliocytes in indigenous and alien inhabitants of the Republic of Tyva with atrophic and non-atrophic gastritis.
Study Design: cross-sectional comparative study in rural areas of the Republic of Tyva.
Material and methods. Clinical examination and endoscopic examination with biopsy sampling from the mucosa of the antrum and gastric body were carried out in 61 Tuvinian and 65 alien inhabitants in the village of Saryg-Sep of the Republic of Tyva, of which 91 people had non atrophic, and 35 — atrophic gastritis. Helicobacter pylori was determined by two methods: morphological and urease. Morphological diagnosis of gastritis was performed in accordance with the modified Sydney classification (1994). The markers of proliferation (Ki67 and PCNA) and apoptosis (bcl-2 and p53) in gastric epithelial cells were assessed by immunohistochemical method.
Study Results. H. pylori was found in 85.2% (52 of 61) of the examined natives and 81.5% (of 53 of 65) of the visitors (odds ratio — 1.29; 95% confidence interval: 0.51–3.26, p = 0.75). In both populations, in patients with atrophy in the antrum and gastric body, the apoptosis index p53 was significantly higher than in patients without atrophy. Proliferation indicators Ki67 and PCNA in gastric epithelial cells significantly decreased in patients with atrophic gastritis compared to those in patients without atrophy among Caucasoids, but not among Tuvinians.
Conclusion. The obtained results indicate deeper disturbances in the cellular renewal of gastric epitheliocytes in alien inhabitants with atrophic gastritis than in indigenous people with this disease. We suggest that indicators characterizing the proliferation of epitheliocytes in patients with atrophic gastritis may be markers of the risk of developing gastric cancer.
About the Authors
V. V. Tsukanov
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of
the Siberian Branch of the Russian Academy of Science”
Russian Federation
Russian Federation
O. V. Peretyat'ko
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of
the Siberian Branch of the Russian Academy of Science”
Russian Federation
Russian Federation
A. V. Vasyutin
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of
the Siberian Branch of the Russian Academy of Science”
Russian Federation
Russian Federation
E. V. Kasparov
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of
the Siberian Branch of the Russian Academy of Science”
Russian Federation
Russian Federation
Yu. L. Tonkikh
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of
the Siberian Branch of the Russian Academy of Science”
Russian Federation
Russian Federation
References
1. Thrift A.P., Nguyen T.H. Gastric cancer epidemiology. Gastrointest. Endosc. Clin. N. Am. 2021; 31(3): 425–39. DOI: 10.1016/j.giec.2021.03.001
2. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68(6): 394– 424. DOI: 10.3322/caac.21492
3. Correa P. Gastric cancer: overview. Gastroenterol. Clin. North. Am. 2013; 42(2): 211–17. DOI: 10.1016/j.gtc.2013.01.002
4. Pimentel-Nunes P., Libânio D., Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019; 51(4): 365–88. DOI: 10.1055/a-0859-1883
5. Banks M., Graham D., Jansen M. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019; 68(9): 1545–75. DOI: 10.1136/gutjnl-2018-318126
6. Gupta S., Li D., El Serag H.B. et al. AGA Clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020; 158(3): 693–702. DOI: 10.1053/j.gastro.2019.12.003
7. Rosania R., Varbanova M., Wex T. et al. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. BMC Gastroenterol. 2017; 17(1): 84. DOI: 10.1186/s12876-017-0640-7
8. Díaz P., Valenzuela Valderrama M., Bravo J. et al. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front. Microbiol. 2018; 9: 5. DOI: 10.3389/fmicb.2018.00005
9. Tsukanov V.V., Butorin N.N., Maady A.S. et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia. Helicobacter. 2011; 16(2): 107–12. DOI: 10.1111/j.1523-5378.2011.00827.x
10. Dixon M.F., Genta R.M., Yardley J.H. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996; 20(10): 1161–81. DOI: 10.1097/00000478-199610000-00001
11. Xia H.H., Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am. J. Gastroenterol. 2001; 96(1): 16–26. DOI: 10.1111/j.1572-0241.2001.03447.x
12. Цуканов В.В., Амельчугова О.С., Каспаров Э.В. и др. Показатели апоптоза в слизистой оболочке желудка у пациентов с атрофическим гастритом среди коренных и пришлых жителей Эвенкии. Терапевтический архив. 2015; 87(2): 11–14. [Tsukanov V.V., Amel'chugova O.S., Kasparov E.V. et al. Indicators of apoptosis in the gastric mucosa in patients with atrophic gastritis among the indigenous and nonindigenous dwellers of Evenkia. Terapeutic Archiv. 2015; 87(2): 11–14. (in Russian)]. DOI: 10.17116/terarkh201587211-14
13. Guarner J., Bartlett J., Seitz R. et al. Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 1 year after Helicobacter pylori eradication. Arch. Pathol. Lab. Med. 2005; 129(11): 1451–6. DOI: 10.5858/2005-129-1451-CPAIOB
14. Jang T.J., Kim J.R. Proliferation and apoptosis in gastric antral epithelial cells of patients infected with Helicobacter pylori. J. Gastroenterol. 2000; 35(4): 265–71. DOI: 10.1007/s005350050344
15. Gao L., Nieters A., Brenner H. Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. Eur. J. Hum. Genet. 2009; 17(12): 1658–67. DOI: 10.1038/ejhg.2009.102
16. Sheh A., Chaturvedi R., Merrell D.S. et al. Phylogeographic origin of Helicobacter pylori determines host-adaptive responses upon coculture with gastric epithelial cells. Infect. Immun. 2013; 81(7): 2468–77. DOI: 10.1128/IAI.01182-12
Review
For citations:
Tsukanov V.V., Peretyat'ko O.V., Vasyutin A.V., Kasparov E.V., Tonkikh Yu.L. Indicators of cellular renewal of gastric epitheliocytes in indigenous and alien inhabitants of the Republic of Tyva with atrophic gastritis. Title. 2022;21(2):30-33. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-2-30-33
Views:
7
Email this article 